Rubio-Beltrán E - Search Results

1

Characterisation of vasodilatory responses in the presence of the CGRP receptor antibody erenumab in human isolated arteries.

Rubio-Beltrán E, Labastida-Ramírez A, Haanes KA, van den Bogaerdt A, Bogers AJ, Dirven C, Danser AJ, Xu C, Snellman J, MaassenVanDenBrink A. Rubio-Beltrán E, et al. Cephalalgia. 2019 Dec;39(14):1735-1744. doi: 10.1177/0333102419863027. Epub 2019 Jul 8. Cephalalgia. 2019. PMID: 31284729

2

Pharmacological analysis of the increases in heart rate and diastolic blood pressure produced by (S)-isometheptene and (R)-isometheptene in pithed rats.

Labastida-Ramírez A, Rubio-Beltrán E, Hernández-Abreu O, Daugherty BL, MaassenVanDenBrink A, Villalón CM. Labastida-Ramírez A, et al. J Headache Pain. 2017 Dec;18(1):52. doi: 10.1186/s10194-017-0761-y. Epub 2017 May 4. J Headache Pain. 2017. PMID: 28474252 Free PMC article.

3

Pharmacological analysis of the inhibition produced by moxonidine and agmatine on the vasodepressor sensory CGRPergic outflow in pithed rats.

Rubio-Beltrán E, Labastida-Ramírez A, Hernández-Abreu O, MaassenVanDenBrink A, Villalón CM. Rubio-Beltrán E, et al. Eur J Pharmacol. 2017 Oct 5;812:97-103. doi: 10.1016/j.ejphar.2017.07.020. Epub 2017 Jul 8. Eur J Pharmacol. 2017. PMID: 28694067

4

Blocking CGRP in migraine patients - a review of pros and cons.

Deen M, Correnti E, Kamm K, Kelderman T, Papetti L, Rubio-Beltrán E, Vigneri S, Edvinsson L, Maassen Van Den Brink A; European Headache Federation School of Advanced Studies (EHF-SAS). Deen M, et al. J Headache Pain. 2017 Sep 25;18(1):96. doi: 10.1186/s10194-017-0807-1. J Headache Pain. 2017. PMID: 28948500 Free PMC article. Review.

5

Gender aspects of CGRP in migraine.

Labastida-Ramírez A, Rubio-Beltrán E, Villalón CM, MaassenVanDenBrink A. Labastida-Ramírez A, et al. Cephalalgia. 2019 Mar;39(3):435-444. doi: 10.1177/0333102417739584. Epub 2017 Oct 30. Cephalalgia. 2019. PMID: 29082826 Free PMC article. Review.

6

Is selective 5-HT_1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?

Rubio-Beltrán E, Labastida-Ramírez A, Villalón CM, MaassenVanDenBrink A. Rubio-Beltrán E, et al. Pharmacol Ther. 2018 Jun;186:88-97. doi: 10.1016/j.pharmthera.2018.01.005. Epub 2018 Jan 17. Pharmacol Ther. 2018. PMID: 29352859 Free article. Review.

7

Protective effects of PACAP in ischemia.

Reglodi D, Vaczy A, Rubio-Beltran E, MaassenVanDenBrink A. Reglodi D, et al. J Headache Pain. 2018 Mar 2;19(1):19. doi: 10.1186/s10194-018-0845-3. J Headache Pain. 2018. PMID: 29500688 Free PMC article. Review.

8

PACAP38 and PAC₁ receptor blockade: a new target for headache?

Rubio-Beltrán E, Correnti E, Deen M, Kamm K, Kelderman T, Papetti L, Vigneri S, MaassenVanDenBrink A, Edvinsson L; European Headache Federation School of Advanced Studies (EHF-SAS). Rubio-Beltrán E, et al. J Headache Pain. 2018 Aug 7;19(1):64. doi: 10.1186/s10194-018-0893-8. J Headache Pain. 2018. PMID: 30088106 Free PMC article. Review.

9

Is CGRP Receptor Blockade Cardiovascularly Safe? Appropriate Studies Are Needed.

Maassen van den Brink A, Rubio-Beltrán E, Duncker D, Villalón CM. Maassen van den Brink A, et al. Headache. 2018 Sep;58(8):1257-1258. doi: 10.1111/head.13402. Headache. 2018. PMID: 30289181 No abstract available.

10

Understanding CGRP and Cardiovascular Risk.

Rubio-Beltrán E, van den Brink AM. Rubio-Beltrán E, et al. Handb Exp Pharmacol. 2019;255:131-140. doi: 10.1007/164_2019_204. Handb Exp Pharmacol. 2019. PMID: 30879200

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters